ETC-159 (IMAGE)
Caption
The team found that Wnt/beta-catenin pathways activate MYBL2 in the nucleus, which regulates several DNA repair genes. In healthy people, this helps maintain stem cells from accumulating mutations. But it can also help some cancers resist DNA damage by PARP inhibitors. These patients could benefit from receiving a drug that blocks this process along with the PARP inhibitor, such as ETC-159.
Credit
Duke-NUS Medical School
Usage Restrictions
Image may only be used with the provided caption and credit.
License
Licensed content